Literature DB >> 18177861

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.

C M Dhaenens1, S Schraen-Maschke, H Tran, V Vingtdeux, D Ghanem, O Leroy, J Delplanque, E Vanbrussel, A Delacourte, P Vermersch, C A Maurage, H Gruffat, A Sergeant, M S Mahadevan, S Ishiura, L Buée, T A Cooper, M L Caillet-Boudin, N Charlet-Berguerand, B Sablonnière, N Sergeant.   

Abstract

Neurofibrillary degeneration is often observed in the brain of patients with type 1 myotonic dystrophy (DM1). It consists principally of the aggregation of Tau isoforms that lack exon 2/3 encoded sequences, and is the consequence of the modified splicing of Tau pre-mRNA. In experimental models of DM1, the splicing of several transcripts is modified due to the loss of Muscleblind-like 1 (MBNL1) function. In the present study, we demonstrate that the MBNL1 protein is also present in the human brain, and consists of several isoforms, as shown by RT-PCR and sequencing. In comparison with controls, we show that the adult DM1 brain exhibits modifications in the splicing of MBNL1, with the preferential expression of long MBNL1 isoforms--a splicing pattern similar to that seen in the fetal human brain. In cultured HeLa cells, the presence of long CUG repeats, such as those found in the DM1 mutation, leads to similar changes in the splicing pattern of MBNL1, and the localization of MBNL1 in nuclear RNA foci. Long CUG repeats also reproduce the repression of Tau exon 2/3 inclusion, as in the human disease, suggesting that their effect on MBNL1 expression may lead to changes in Tau splicing. However, while an overall reduction in the expression of MBNL1 mimics the effect of the DM1 mutation, none of the MBNL1 isoforms tested so far modulates the endogenous splicing of Tau. The modified splicing of Tau thus results from a possibly CUG-mediated loss of function of MBNL1, but not from changes in the MBNL1 expression pattern.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177861     DOI: 10.1016/j.expneurol.2007.11.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  28 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 2.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

3.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

Review 4.  The role of CELF proteins in neurological disorders.

Authors:  Jean-Marc Gallo; Carl Spickett
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

Review 5.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

6.  Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.

Authors:  Hélène Tran; Nathalie Gourrier; Camille Lemercier-Neuillet; Claire-Marie Dhaenens; Audrey Vautrin; Francisco José Fernandez-Gomez; Ludovic Arandel; Céline Carpentier; Hélène Obriot; Sabiha Eddarkaoui; Lucie Delattre; Edwige Van Brussels; Ian Holt; Glenn E Morris; Bernard Sablonnière; Luc Buée; Nicolas Charlet-Berguerand; Susanna Schraen-Maschke; Denis Furling; Isabelle Behm-Ansmant; Christiane Branlant; Marie-Laure Caillet-Boudin; Nicolas Sergeant
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

7.  Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.

Authors:  Sharan Paul; Warunee Dansithong; Sonali P Jog; Ian Holt; Saloni Mittal; J David Brook; Glenn E Morris; Lucio Comai; Sita Reddy
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

8.  MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.

Authors:  Marianne Goodwin; Apoorva Mohan; Ranjan Batra; Kuang-Yung Lee; Konstantinos Charizanis; Francisco José Fernández Gómez; Sabiha Eddarkaoui; Nicolas Sergeant; Luc Buée; Takashi Kimura; H Brent Clark; Joline Dalton; Kenji Takamura; Sebastien M Weyn-Vanhentenryck; Chaolin Zhang; Tammy Reid; Laura P W Ranum; John W Day; Maurice S Swanson
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

Review 9.  Pathogenic RNAs in microsatellite expansion disease.

Authors:  Jihae Shin; Konstantinos Charizanis; Maurice S Swanson
Journal:  Neurosci Lett       Date:  2009-08-04       Impact factor: 3.046

10.  RNA gain-of-function in spinocerebellar ataxia type 8.

Authors:  Randy S Daughters; Daniel L Tuttle; Wangcai Gao; Yoshio Ikeda; Melinda L Moseley; Timothy J Ebner; Maurice S Swanson; Laura P W Ranum
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.